Predictors of Microvascular Invasion Before Hepatectomy for Hepatocellular Carcinoma

被引:192
作者
Kaibori, Masaki [1 ]
Ishizaki, Morihiko [1 ]
Matsui, Kosuke [1 ]
Kwon, A-Hon [1 ]
机构
[1] Kansai Med Univ, Dept Surg, Hirakata Hosp, Osaka 5731191, Japan
关键词
liver cancer; hepatectomy; microvascular invasion; predictors; GAMMA-CARBOXY PROTHROMBIN; LIVER-TRANSPLANTATION; RESECTION; THERAPY; RECURRENCE; PROTEIN;
D O I
10.1002/jso.21631
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background and Objectives: Microvascular invasion (MVI) is difficult to detect before resection of hepatocellular carcinoma (HCC) Methods: Clinicopathological and outcome data were retrospectively compared between 213 HCC patients with M VI and 221 patients without MVI who underwent hepatectomy Results: M VI risk was selected as an independent prognostic indicator for both disease-free and overall survival in our 434 HCC patients Univariate and multivariate analyses showed that an age under 65 years, a protein induced by vitamin K absence/antagonism II (PIVKA-II) level >= 200 mAU/ml. a preoperative tumor size >= 5 0 cm. and poorly differentiated carcinoma were independent predictors of MVI When age. PIVKA-II level, and tumor size (data available before surgery) were scored as a combined index, the total score demonstrated a significant correlation with the extent of vascular invasion and with survival after hepatic resection Conclusions: An age under 65 years. increase of PIVKA-II. and larger tumor size were preoperative predictors of MVI in HCC patients undergoing potentially curative resection Our combined score based on the age. serum PIVKA-II. and preoperative tumor size is a reliable predictor of NI VI and survival in patients with HCC J Surg Oncol 2010,102 462-468 (C) 2010 Wiley-Liss, Inc
引用
收藏
页码:462 / 468
页数:7
相关论文
共 32 条
[1]  
[Anonymous], 2000, HPB, DOI DOI 10.1080/136518202760378489
[2]  
[Anonymous], 2003, General Rules for the Clinical and Pathological Study ofPrimary Liver Cancer, V2nd
[3]  
[Anonymous], 1957, FOIE ETUDES ANATOMIQ
[4]  
[Anonymous], 1997, J CLIN PATHOL
[5]   Hepatocellular carcinoma: Diagnosis and treatment [J].
Befeler, AS ;
Di Bisceglie, AM .
GASTROENTEROLOGY, 2002, 122 (06) :1609-1619
[6]   Liver transplantation for hepatocellular carcinoma [J].
Bismuth, H ;
Majno, PE ;
Adam, R .
SEMINARS IN LIVER DISEASE, 1999, 19 (03) :311-322
[7]   Epidemiology of primary liver cancer [J].
Bosch, FX ;
Ribes, J ;
Borràs, J .
SEMINARS IN LIVER DISEASE, 1999, 19 (03) :271-285
[8]   Predictors and patterns of recurrence after resection of hepatocellular carcinoma [J].
Cha, C ;
Fong, YM ;
Jarnagin, WR ;
Blumgart, LH ;
DeMatteo, RP .
JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2003, 197 (05) :753-758
[9]   A prospective randomized trial comparing percutaneous local ablative therapy and partial hepatectomy for small hepatocellular carcinoma [J].
Chen, MS ;
Li, JQ ;
Zheng, Y ;
Guo, RP ;
Liang, HH ;
Zhang, YQ ;
Lin, XJ ;
Lau, WY .
ANNALS OF SURGERY, 2006, 243 (03) :321-328
[10]   Rising incidence of hepatocellular carcinoma in the United States [J].
El-Serag, HB ;
Mason, AC .
NEW ENGLAND JOURNAL OF MEDICINE, 1999, 340 (10) :745-750